Literature DB >> 18226534

An automated synthesis of N,N-dimethyl-2-(2-amino-4-[18F]fluorophenylthio)benzylamine (4-[18F]-ADAM) for imaging serotonin transporters.

Chi-Jiun Peng1, Ya-Yao Huang, Wen-Sheng Huang, Chyng-Yann Shiue.   

Abstract

N,N-dimethyl-2-(2-amino-4-[(18)F]fluorophenylthio)benzylamine (4-[(18)F]-ADAM, 3) is a potent serotonin transporter (SERT) imaging agent. In order to fulfill the demand of pre-clinical studies, we have developed an automated synthesis unit to synthesize this radioligand. The 4-[(18)F]-ADAM was synthesized using TracerLab FN and FE modules and a modified module control program (TracerLab-Fx). The synthesis sequences were similar to that of the manual synthesis, i.e. nucleophilic fluorination of N,N-dimethyl-2-(2,4-dinitrophenylthio)benzylamine (1) with K[(18)F]/K(2.2.2) followed by reduction with NaBH(4)/Cu(OAc)(2) and purifications with high-performance liquid chromatography (HPLC) and solid phase extraction. The radiochemical yield of 3 was 1.5+/-0.3% (n=13, EOS). The synthesis time was 120 min and the specific activity was 1.75+/-0.77 Ci/micromol (n=13, EOS). The 4-[(18)F]-ADAM synthesized by this module was stable over 4h at room temperature and is suitable for imaging SERT in humans.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18226534     DOI: 10.1016/j.apradiso.2007.11.009

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  9 in total

1.  PET imaging of the brain serotonin transporters (SERT) with N,N-dimethyl-2-(2-amino-4-[18F]fluorophenylthio)benzylamine (4-[18F]-ADAM) in humans: a preliminary study.

Authors:  Wen-Sheng Huang; San-Yuan Huang; Pei-Shen Ho; Kuo-Hsing Ma; Ya-Yao Huang; Chin-Bin Yeh; Ren-Syuan Liu; Cheng-Yi Cheng; Chyng-Yann Shiue
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-10-05       Impact factor: 9.236

2.  Preliminary Results on the Long-Term Effects of Dextromethorphan on MDMA-Mediated Serotonergic Deficiency and Volumetric Changes in Primates Based on 4-[18F]-ADAM PET/MRI.

Authors:  Skye Hsin-Hsien Yeh; Yu-Yeh Kuo; Wen-Sheng Huang; Chuang-Hsin Chiu; Tsung-Hsun Yu; Leo Garcia Flores Ii; Chi-Jung Tsai; Cheng-Yi Cheng; Kuo-Hsing Ma
Journal:  Front Neurosci       Date:  2022-05-19       Impact factor: 5.152

3.  2-(2'-((Dimethylamino)methyl)-4'-(3-[(18)F]fluoropropoxy)-phenylthio)benzenamine for positron emission tomography imaging of serotonin transporters.

Authors:  Julie L Wang; Ajit K Parhi; Shunichi Oya; Brian Lieberman; Mei-Ping Kung; Hank F Kung
Journal:  Nucl Med Biol       Date:  2008-05       Impact factor: 2.408

4.  Biodistribution, toxicity and radiation dosimetry studies of the serotonin transporter radioligand 4-[18F]-ADAM in rats and monkeys.

Authors:  Ya-Yao Huang; Kuo-Hsing Ma; Ta-Wei Tseng; Ta-Kai Chou; Hanna Ng; Jon C Mirsalis; Ying-Kai Fu; Tieh-Chi Chu; Wen-Sheng Huang; Chyng-Yann Shiue
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-10-10       Impact factor: 9.236

Review 5.  5-HT radioligands for human brain imaging with PET and SPECT.

Authors:  Louise M Paterson; Birgitte R Kornum; David J Nutt; Victor W Pike; Gitte M Knudsen
Journal:  Med Res Rev       Date:  2011-06-14       Impact factor: 12.944

6.  Incongruent reduction of serotonin transporter associated with suicide attempts in patients with major depressive disorder: a positron emission tomography study with 4-[18F]-ADAM.

Authors:  Yi-Wei Yeh; Pei-Shen Ho; Chun-Yen Chen; Shin-Chang Kuo; Chih-Sung Liang; Kuo-Hsing Ma; Chyng-Yann Shiue; Wen-Sheng Huang; Cheng-Yi Cheng; Tzu-Yun Wang; Ru-Band Lu; San-Yuan Huang
Journal:  Int J Neuropsychopharmacol       Date:  2014-10-31       Impact factor: 5.176

7.  Disproportionate Reduction of Serotonin Transporter May Predict the Response and Adherence to Antidepressants in Patients with Major Depressive Disorder: A Positron Emission Tomography Study with 4-[18F]-ADAM.

Authors:  Yi-Wei Yeh; Pei-Shen Ho; Shin-Chang Kuo; Chun-Yen Chen; Chih-Sung Liang; Che-Hung Yen; Chang-Chih Huang; Kuo-Hsing Ma; Chyng-Yann Shiue; Wen-Sheng Huang; Jia-Fwu Shyu; Fang-Jung Wan; Ru-Band Lu; San-Yuan Huang
Journal:  Int J Neuropsychopharmacol       Date:  2015-01-07       Impact factor: 5.176

8.  Recent progress of imaging agents for Parkinson's disease.

Authors:  Xiaoai Wu; Huawei Cai; Ran Ge; Lin Li; Zhiyun Jia
Journal:  Curr Neuropharmacol       Date:  2014-12       Impact factor: 7.363

9.  Toxicity and radiation dosimetry studies of the serotonin transporter radioligand [(18) F]AFM in rats and monkeys.

Authors:  Ya-Yao Huang; Chen-Yi Cheng; Wen-Sheng Huang; Kuo-Hsing Ma; Ta-Wei Tseng; Ta-Kai Chou; Yiyun Huang; Chyng-Yann Shiue
Journal:  EJNMMI Res       Date:  2014-12-29       Impact factor: 3.138

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.